-+ 0.00%
-+ 0.00%
-+ 0.00%

Windtree Therapeutics Q4 EPS $(4.63) Beats $(28.82) Estimate

Benzinga·05/16/2025 12:08:25
Listen to the news
Windtree Therapeutics (NASDAQ:WINT) reported quarterly losses of $(4.63) per share which beat the analyst consensus estimate of $(28.82) by 83.93 percent. This is a 100.42 percent decrease over earnings of $1.10 thousand per share from the same period last year.